Edition:
India

Curis Inc (CRIS.OQ)

CRIS.OQ on NASDAQ Stock Exchange Global Market

0.76USD
16 Jan 2018
Change (% chg)

-- (--)
Prev Close
$0.76
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
285,953
52-wk High
$3.22
52-wk Low
$0.67

Chart for

About

Curis, Inc. is a biotechnology company seeking to develop and commercialize drug candidates for the treatment of cancers. The Company's drug candidate is CUDC-907, an orally-available, small molecule inhibitor of histone deacetylase (HDAC) and phosphatidylinositol-3-kinase (PI3K) enzymes. CUDC-907 is an oral, dual inhibitor of... (more)

Overall

Beta: 1.86
Market Cap(Mil.): $263.85
Shares Outstanding(Mil.): 163.88
Dividend: --
Yield (%): --

Financials

BRIEF-Curis announces pricing of public offering of common stock

* Curis Inc - pricing of an underwritten public offering of 20 million shares of its common stock​ Source text for Eikon: Further company coverage:

14 Sep 2017

BRIEF-Curis and Aurigene announce CA-170 program update following data presented at ESMO 2017

* Curis and Aurigene announce CA-170 program update following data presented at ESMO 2017

11 Sep 2017

BRIEF-Curis reports Q2 loss per share $0.10

* Q2 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

03 Aug 2017

Earnings vs. Estimates